The Effect of Virtual Reality Application Diagnosed With Myocardial Infarction

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorYuzuncu Yil University

About this trial

This study was designed to investigate the effects of VR (virtual reality) glasses on vital signs and anxiety in conscious patients diagnosed with myocardial infarction and admitted to the cardiology intensive care unit.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

The patient is in intensive care.

The patient has been diagnosed with myocardial infarction.

The patient is between 18 and 70 years old.

The patient is conscious.

Disqualifiers

The patient has a psychiatric disorder.

The patient has any communication impairment.

Trial design

Design model

Parallel

Treatments tested in this trial

  • virtual reality glasses

    Other intervention

    Participants will be shown a video with nature images through virtual reality glasses, and their vital signs and anxiety levels will be measured.

Treatment groups

50 Participants
are divided into 2 treatment groups
Group A: EXPERIMENTAL GROUPExperimental treatment 1 intervention
Group B: CONTROL GROUPNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Anxiety Level

The patient's anxiety level will be measured using the State Anxiety Scale (STAI Form TX-1).

Time frame
Periprocedural
2

Vital Signs - Blood pressure measurements (SBP, DBP)

Blood pressure measurements (SBP, DBP)

Time frame
Periprocedural
3

Vital Signs- heart rate

heart rate will be taken.

Time frame
Periprocedural
4

Vital Signs - respiratory rate per minute

respiratory rate per minute will be taken.

Time frame
Periprocedural

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.